Marimed (MRMD) Assets Average (2011 - 2026)
Marimed's (MRMD) quarterly Assets Average came in at $201.9 million in Q1 2026, down 2.71% year-on-year from $207.5 million in Q1 2025, and up 99.31% on a QoQ basis from $101.3 million in Q4 2025.
Marimed (MRMD) Assets Average (2011 - 2026) Analysis & Trends
Marimed (MRMD) has 16 years of Assets Average data on file, last reported at $201.9 million in Q1 2026.
- On a quarterly basis, Assets Average fell 2.71% year-over-year to $201.9 million in Q1 2026; TTM through Mar 2026 was $201.9 million, a 2.71% decrease from a year earlier, with the FY2025 full-year figure at $204.8 million, up 1.6% from the prior year.
- Assets Average for Q1 2026 stood at $201.9 million, up from $101.3 million in the prior quarter.
- Over the last five years, Assets Average for MRMD reached as high as $210.6 million in Q3 2024 and fell as low as $101.3 million in Q4 2025.
- Historically, Assets Average has averaged $172.8 million across 5 years, with a median of $190.1 million in 2023.
- Across the five-year window, Assets Average surged 56.33% in 2022 and slumped 51.73% in 2025, its largest moves.
- Year by year, Assets Average stood at $148.4 million in 2022, then surged by 30.33% to $193.5 million in 2023, then advanced by 8.46% to $209.8 million in 2024, then slumped by 51.73% to $101.3 million in 2025, then surged by 99.31% to $201.9 million in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $201.9 million in Q1 2026, $101.3 million in Q4 2025, and $102.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Marimed | 23.85 Mn | 14.02 Mn | 15.28 Mn | 201.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 201.88 Mn |
| Dec 31, 2025 | 101.29 Mn |
| Sep 30, 2025 | 102.19 Mn |
| Jun 30, 2025 | 206.19 Mn |
| Mar 31, 2025 | 207.49 Mn |
| Dec 31, 2024 | 209.84 Mn |
| Sep 30, 2024 | 210.61 Mn |
| Jun 30, 2024 | 204.93 Mn |
| Mar 31, 2024 | 198.73 Mn |
| Dec 31, 2023 | 193.47 Mn |
| Sep 30, 2023 | 190.09 Mn |
| Jun 30, 2023 | 186.88 Mn |
| Mar 31, 2023 | 168.30 Mn |
| Dec 31, 2022 | 148.45 Mn |
| Sep 30, 2022 | 140.29 Mn |
| Jun 30, 2022 | 136.43 Mn |
| Mar 31, 2022 | 130.09 Mn |
| Dec 31, 2021 | 120.72 Mn |
| Sep 30, 2021 | 110.56 Mn |
| Jun 30, 2021 | 96.43 Mn |